Comparing cervical versus thoracic trans‑spinal magnetic stimulation added to brain TMS to improve walking in Parkinson's disease
Official title: Effects of the Stimulation Site of Trans-spinal Magnetic Stimulation Combined With Transcranial Magnetic Stimulation on Functional Mobility in Individuals With Parkinson's Disease
Run by Universidade Federal de Pernambuco · NCT07488026 · Data updated 2026-11-12
This trial will test whether adding cervical or thoracic trans‑spinal magnetic stimulation to repetitive brain TMS helps people with Parkinson's and gait problems walk better and move more easily.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Universidade Federal de Pernambuco Academic / other |
| Locations | 1 site (Recife, Pernambuco) |
| Status | Recruiting |
| Started | January 5, 2026 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT07488026 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 40 or older with a neurologist‑confirmed Parkinson's diagnosis, stable dopaminergic medication for at least three months, disease stage about 2.5–3 on the modified Hoehn and Yahr scale, and at least one freezing‑of‑gait episode per week who have no contraindications to magnetic stimulation.
✕Probably not a fit
Patients with other neurological, vestibular, severe musculoskeletal or visual impairments, prior Parkinson's surgery, MoCA score under 21, a history of seizures, or metal implants in the neck or spine are unlikely to benefit or may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
People with Parkinson's disease and frequent freezing of gait are randomized to receive repetitive transcranial magnetic stimulation (rTMS) combined with either cervical or thoracic trans‑spinal magnetic stimulation (tsMS). Each participant completes a course of 10 treatment sessions and outcomes are measured before and after the intervention. Primary outcomes include functional mobility and gait speed, with secondary measures of motor function, freezing episodes, balance, quality of life, patient‑reported global improvement, and adverse events. The comparison aims to identify whether the site of tsMS application produces different effects on mobility and motor outcomes.
Why it matters
Potential benefit: If successful, this approach could identify the best spinal stimulation site to improve walking and reduce freezing in people with Parkinson's, leading to more effective adjunct treatments.
How similar studies have gone: Small studies have reported motor or gait benefits from rTMS or trans‑spinal stimulation alone, but directly comparing cervical versus thoracic tsMS combined with rTMS is relatively novel and not yet well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: (i) a clinical diagnosis of Parkinson's disease confirmed by a neurologist; (ii) stable dopaminergic pharmacological treatment for at least three months; (iii) age 40 years or older; (iv) disease stage between 2.5 and 3 on the modified Hoehn and Yahr scale; (v) (v) gait impairment, defined as the occurrence of at least one freezing of gait episode per week. \- Exclusion Criteria: (i) other neurological disorders, orthostatic hypotension, vestibular, musculoskeletal, or visual impairments that could compromise performance on the proposed assessments; (ii) other osteomuscular conditions affecting the lower limbs that interfere with mobility and functional performance; (iii) a Montreal Cognitive Assessment (MoCA) score lower than 21 points; (iv) prior surgical procedures for Parkinson's disease; or (v) contraindications to magnetic stimulation techniques, including a history of seizures or the presence of metallic implants in the neck or spinal region.
Where it's running
-
Universidade Federal de Pernambuco
Recife, Pernambuco, Brazil Recruiting
Study contacts
- Study coordinator: Ana Cecília Ribeiro Nascimento, Msc. student
- Email: anaceciliaribeiro.n@gmail.com
- Phone: (81) 99893-6664
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Automated language analysis to help diagnose neurodegenerative diseases
A multilingual AI-powered language test is being tried to see if speech and language patterns can help differentiate Alzheimer’s, frontotemporal dementia, Lewy body dementia, and Parkinson’s from healthy aging.
-
Brain alpha-synuclein PET imaging in Parkinson's patients and healthy seniors
This open-label study tests a radioactive tracer called [18F]MK-0947 to see how it behaves in the brains of people with Parkinson's disease compared with healthy elderly volunteers.
-
Parkinson’s self-sufficiency and rehabilitation in a Czech spa setting
This intervention tests whether a Czech self-sufficiency test can be used with people with Parkinson’s disease and sees how spa-based rehabilitation affects independence, cognition, balance, and walking.
-
Imaging PD progression with [18F]AV-133 using high- and standard-resolution PET
This study tests how [18F]AV-133 PET imaging changes over 12 months in people with Parkinson's disease and a small group of healthy controls.
-
Microelectrode-based brain stimulation for Parkinson’s and essential tremor
This early feasibility test checks a new microelectrode-based brain stimulation method in adults with Parkinson’s disease or essential tremor who are already getting deep brain stimulation implants.
-
Sleep and adaptive DBS in Parkinson’s disease
This study tests whether adjusting adaptive deep brain stimulation during sleep can improve sleep quality and brain activity in people with Parkinson’s disease who already have DBS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.